/FPSUF
FPSUF Stock - Capha Pharmaceuticals Inc.
Healthcare|Drug Manufacturers - Specialty & GenericOTC
$0.00+0.00%
+$0.00 (+0.00%) • Dec 5
51
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.50
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.19
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for FPSUF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.00 – $0.00
TARGET (TP)$0.00
STOP LOSS$0.00
RISK/REWARD1:-1.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta2.53
52W High$0.00
52W Low$0.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | $-141.514 | $-209.701 | $-310.273 | $-482.367 |
| Gross Margin | N/A | N/A | N/A | N/A | N/A |
| Operating Income | $-50,745 | $-53,140 | $-57,890 | $-44,800 | $-50,710 |
| Net Income | $-70,773 | $-53,362 | $-58,307 | $-44,806 | $-51,160 |
| Net Margin | N/A | N/A | N/A | N/A | N/A |
| EPS | $-0.00 | $-0.00 | $-0.00 | $-0.00 | $-0.00 |
Company Overview
Capha Pharmaceuticals Inc. does not have significant operations. It intends to explore opportunities in the pharmaceutical distribution business. The company was formerly known as FPS Pharma Inc. and changed its name to Capha Pharmaceuticals Inc. in January 2017. Capha Pharmaceuticals Inc. was incorporated in 2004 and is based in West Kelowna, Canada.
Loading analyst ratings...
Earnings History & Surprises
FPSUFLoading earnings data...
Latest News
Loading news...
Frequently Asked Questions about FPSUF
What is FPSUF's current stock price?
Capha Pharmaceuticals Inc. (FPSUF) is currently trading at $0.00 per share. The stock has moved +0.00% today.
What is the analyst price target for FPSUF?
No analyst price targets are currently available for this stock.
What sector is Capha Pharmaceuticals Inc. in?
Capha Pharmaceuticals Inc. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.
What is FPSUF's market cap?
Capha Pharmaceuticals Inc. has a market capitalization of $0.00 billion, making it a small-cap company.
Does FPSUF pay dividends?
No, Capha Pharmaceuticals Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorABMC
American Bio Medica Corporation
$0.00
Mkt Cap: $0.0B
ACCA
Acacia Diversified Holdings, Inc.
$0.00
Mkt Cap: $0.0B
CRXM
Gene Biotherapeutics, Inc.
$0.00
Mkt Cap: $0.0B
CRYO
American CryoStem Corporation
$0.00
Mkt Cap: $0.0B
EQUR
E-Qure Corp.
$0.00
Mkt Cap: $0.0B
GDBYF
Goodbody Health Limited
$0.00
Mkt Cap: $0.0B
GLSHQ
Gelesis Holdings, Inc.
$0.00
Mkt Cap: $0.0B
HBOSF
EastWest Bioscience Inc.
$0.00
Mkt Cap: $0.0B
INTP
Integrated Pharmaceuticals, Inc.
$0.00
Mkt Cap: $0.0B
TAUG
Tauriga Sciences, Inc.
$0.00
Mkt Cap: $0.0B
Explore stocks similar to FPSUF for comparison